This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Sri International, Leland Stanford Junior University, The Cooper Health System. Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Los Alto, CA (US) (2012)
- Menlo Park, CA (US) (2014)
- Los Altos, CA (US) (2013 - 2018)
Company Filing History:



Years Active: 2012-2018
Title: Mary Jean Tanga: Innovator in Pharmaceutical Research
Introduction
Mary Jean Tanga is a prominent inventor based in Los Altos, California, known for her significant contributions to pharmaceutical research. With a total of six patents, she has made remarkable strides in the treatment of various medical conditions, particularly in the fields of depression and neuropathic pain.
Latest Patents
Among her latest patents is the innovative use of (2R, 6R)-hydroxynorketamine and (S)-dehydronorketamine, along with other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine. This patent focuses on pharmaceutical preparations that provide effective treatment for depression and neuropathic pain. The disclosure outlines methods for treating bipolar depression, major depressive disorder, and chronic pain by administering purified ketamine metabolites or their prodrugs directly to patients in need. Another notable patent involves benzyl urea derivatives aimed at activating TGF-beta signaling, which are useful in treating disorders characterized by reduced TGF-B signaling, including Alzheimer's disease.
Career Highlights
Mary Jean Tanga has worked with esteemed organizations such as SRI International and the National Institutes of Health, a component of the U.S. Department of Health & Human Services. Her work has been instrumental in advancing research and developing new therapeutic approaches.
Collaborations
Throughout her career, Tanga has collaborated with notable professionals in her field, including Anton Wyss-Coray and Irving William Wainer. These collaborations have further enriched her research and contributed to her innovative work.
Conclusion
Mary Jean Tanga's contributions to pharmaceutical research and her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for new treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile